drugset / Trial / NCT03329898

Comparing the Efficacy of Two Methods for the Therapy of Uterine Adhesion

NCT03329898

RandomizedParallel-groupDouble-blindPrevention

Summary

Asherman's syndrome is characterized by the presence of intrauterine adhesions (IUA) as well as symptoms such as amenorrhea, hypomenorrhea, pelvic pain, and infertility. The gold standard for the treatment of intrauterine adhesions is hysteroscopic intrauterine adhesions. The recurrence of intrauterine adhesions is a major challenge in clinical practice. It has been reported that dried biological aminion graft was used to prevent adhesion after the operation of intrauterine adhesions. Intrauterine balloon can reduce the recurrence of adhesions after operation. Does the combination of balloon and amniotic products can improve clinical outcomes? Therefore, this study was conducted.

Timeline

Start
2017-10-31
Primary completion
2018-10-25
Completion
2018-11-25

Drugs

EvaluationDrugModalityDoseRoute
Background Dydrogesterone Other / unclassified Oral
Background estradiol valerate Unknown Oral

Indications